Companies: 10,795·Total market cap: $144.5T
ViewRay, Inc.

ViewRay, Inc.

VRAYNASDAQHealthcare
$0.03
+$0.00(+0.00%)
Market Cap$4557773
P/E Ratio
52W High$0.0397
52W Low$0.0245
SEC Filings

ViewRay, Inc. (VRAY) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001597313 · VRAY · NASDAQ · as of Jun 9, 2026

Filing snapshot

702
Total Filings
SC 13G/A
Latest Form
2024-02-14
Most Recent
2015
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001597313 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-04-28
Fiscal Year End
Apr 28, 2023
Accession No.
0001628280-23-014271
Primary Document
vray-20221231.htm
Source: data.sec.gov · CIK 0001597313 · Accession 0001628280-23-014271

Latest Key Filings

10-QQuarterly Report
10-Q
2023-05-11
8-KCurrent Report
8-K
2023-09-07Material Event
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2024-02-14
View
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2024-02-12
View
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2024-02-07
View
25-NSE25-NSE
25-NSE
2023-09-08
View
8-KCurrent Report
8-K
2023-09-07
View
NT 10-QNT 10-Q
NT 10-Q
2023-08-14
View
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2023-08-08
View
8-KCurrent Report
8-K
2023-08-03
View
3Initial Statement of Beneficial Ownership
FORM 3
2023-07-26
View
3Initial Statement of Beneficial Ownership
FORM 3
2023-07-26
View
SC 13D/ASC 13D/A
SC 13D/A
2023-07-25
View
SC 13D/ASC 13D/A
SC 13D/A
2023-07-21
View
8-KCurrent Report
8-K
2023-07-21
View
8-KCurrent Report
8-K
2023-07-17
View
8-KCurrent Report
8-K
2023-07-07
View
Showing 1–15 of 416 filingsForm 4 / 144 hidden· 702 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001597313  |  Exchange: NASDAQ · Healthcare

ViewRay, Inc. (NASDAQ: VRAY) has submitted 702 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001597313, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is ViewRay, Inc.'s most comprehensive regulatory disclosure. The most recent ViewRay, Inc. 10-K was filed on 2023-04-28 for fiscal year ending 2023. Historical VRAY 10-K annual reports are available from 2014 through 2023.

Investors researching ViewRay, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

VRAY SEC Filings · 8 questions

ViewRay, Inc. (VRAY) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 702 filings and access original documents at no cost. ViewRay, Inc.'s CIK is 0001597313.

VRAY SEC filingsViewRay, Inc. SEC documentsfind VRAY 10-K